98%
921
2 minutes
20
Background: The first commercialized single-use duodenoscope was cleared by the US Food and Drug Administration in December 2019. Data regarding endoscopic retrograde cholangiopancreatography (ERCP) using a single-use duodenoscope are needed on a broader range of cases conducted by endoscopists with varying levels of experience in a wide range of geographic areas.
Methods: 61 endoscopists at 22 academic centers in 11 countries performed ERCP procedures in adult patients aged ≥ 18. Outcomes included ERCP completion for the intended indication, rate of crossover to a reusable endoscope, device performance ratings, and serious adverse events (SAEs).
Results: Among 551 patients, 236 (42.8 %) were aged > 65, 281 (51.0 %) were men, and 256 (46.5 %) had their procedure as an inpatient. ERCPs included 196 (35.6 %) with American Society for Gastrointestinal Endoscopy complexity of grades 3-4. A total of 529 ERCPs (96.0 %) were completed: 503 (91.3 %) using only the single-use duodenoscope, and 26 (4.7 %) with crossover to a reusable endoscope. There were 22 ERCPs (4.0 %) that were not completed, of which 11 (2.0 %) included a crossover and 11 (2.0 %) were aborted cases (no crossover). Median ERCP completion time was 24.0 minutes. Median overall satisfaction with the single-use duodenoscope was 8.0 (scale of 1 to 10 [best]). SAEs were reported in 43 patients (7.8 %), including 17 (3.1 %) who developed post-ERCP pancreatitis.
Conclusions: In academic medical centers over a wide geographic distribution, endoscopists with varying levels of experience using the first marketed single-use duodenoscope had good ERCP procedural success and reported high performance ratings for this device.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684334 | PMC |
http://dx.doi.org/10.1055/a-2131-7180 | DOI Listing |
Endosc Int Open
July 2025
Centre for Health Economics at Warwick, Warwick Medical School, University of Warwick, Coventry, United Kingdom of Great Britain and Northern Ireland.
Background And Study Aims: Future decision making on health care will need to consider broader environmental and sustainability issues. One example is adoption of single-use endoscopes instead of reusable endoscopes in gastroenterology, largely due to their perceived benefit of reducing cross-infection. Besides considerations related to technical performance, there are differences not only in the cost to healthcare but also in the impact they have on the environment.
View Article and Find Full Text PDFWorld J Gastrointest Endosc
June 2025
Department of Gastroenterology and Hepatology, Boston Medical Center, Boston University, Boston, MA 02135, United States.
Background: Single-use duodenoscopes (SDs) were introduced to eliminate exogenous infection risks post-endoscopic retrograde cholangiopancreatography (ERCP).
Aim: To evaluate their efficacy and safety against reusable duodenoscopes (RDs).
Methods: This was a single-center case control study.
Gastrointest Endosc
March 2025
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv, Israel.
Gastrointest Endosc
March 2025
Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, California, USA.
Am J Gastroenterol
May 2025
Goethe University Frankfurt, University Hospital, Medical Clinic 1, Germany.